| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |